Stuart Poulton - EVP, Chief Development Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Development Officer
Issuer Symbol
KPTI on Nasdaq
All Insider Reports
All Insider Reports

Stuart Poulton - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 94,328 $887,579 $9.41 02 Mar 2026 Direct
Stock Option (right to buy) 9,166 28 Feb 2025 Direct Common Stock

Transactions reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.